SELB - セレクタ・バイオサイエンシズ (Selecta Biosciences Inc.)

SELBのニュース

   Selecta Biosciences Reports First Quarter 2020 Financial Results  2020/05/07 11:30:00 GlobeNewswire
- Topline data announcement from the ongoing head-to-head COMPARE trial of SEL-212 remains on schedule for Q3 2020 - - Phase 3 clinical program of SEL-212…
   Earnings Scheduled For March 12, 2020  2020/03/12 08:51:26 Benzinga Feeds
Companies Reporting Before The Bell Dollar General Corporation (NYSE: DG ) is projected to report quarterly earnings at $2.02 per share on revenue of $7.15 billion. Genesco Inc. (NYSE: GCO ) is estimated to report quarterly earnings at $2.75 per share on revenue of $680.43 million. BEST Inc. (NYSE: BEST ) is expected to report quarterly earnings at $0.42 per share on revenue of $10.90 billion. 58.com Inc. (NYSE: WUBA ) is projected to report quarterly earnings at $0.80 per share on revenue of $587.26 million. Genesis Healthcare, Inc. (NYSE: GEN ) is estimated to report quarterly loss at $0.11 per share on revenue of $1.09 billion. Spartan Motors, Inc. (NASDAQ: SPAR ) is expected to report quarterly earnings at $0.36 per share on revenue of $230.00 million. Party City Holdco Inc. (NYSE: PRTY ) is estimated to report quarterly earnings at $0.88 per share on revenue of $748.82 million. RadNet, Inc. (NASDAQ: RDNT ) is projected to report quarterly earnings at $0.15 per share on revenue of $294.16 million.
   Selecta Biosciences to Host Conference Call and Webcast to Discuss Fourth Quarter and Full-Year 2019 Financial Results and Recent Operational Highlights | MarketScreener  2020/03/05 13:01:10 MarketScreener
WATERTOWN, Mass., March 05, 2020 -- Selecta Biosciences, Inc. , a clinical-stage biotechnology company focused on unlocking the full potential of biologic therapies based on its immune… | March 5, 2020
   The Daily Biotech Pulse: LogicBio Slapped With Clinical Hold, Agile Inks Debt Deal Ahead of Twirla Approval, Gilead Builds Stake In Sierra Oncology  2020/02/11 12:23:06 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Feb. 10) AbbVie Inc (NYSE: ABBV ) Allergan plc (NYSE: AGN ) )(reacted to better-than-expected results and comments that its deal to be acquired by AbbVie is on track to close by the first quarter) Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY ) Apellis Pharmaceuticals Inc (NASDAQ: APLS ) Aptose Biosciences Inc (NASDAQ: APTO ) Arcutis Biotherapeutics Inc (NASDAQ: ARQT ) Ascendis Pharma A/S (NASDAQ: ASND ) AtriCure Inc. (NASDAQ: ATRC ) ChemoCentryx Inc (NASDAQ: CCXI ) Co-Diagnostics Inc (NASDAQ: CODX )(announced sales of its new coronavirus test ) Cue Biopharma Inc (NASDAQ: CUE ) Deciphera Pharmaceuticals Inc (NASDAQ: DCPH ) DexCom, Inc. (NASDAQ: DXCM ) Esperion Therapeutics Inc (NASDAQ: ESPR ) Fulgent Genetics Inc (NASDAQ: FLGT ) GALAPAGOS NV/S ADR (NASDAQ: GLPG ) Insulet Corporation (NASDAQ: PODD ) Kodiak Sciences Inc (NASDAQ: KOD )(reacted to positive data readout from early-stage study of experimental drug to treat eye disorders) Masimo Corporation (NASDAQ: MASI ) Novartis AG (NYSE: NVS ) Pacira Biosciences Inc (NASDAQ: PCRX ) Principia Biopharma Inc (NASDAQ: PRNB ) PTC Therapeutics, Inc (NASDAQ: PTCT ) Revance Therapeutics Inc (NASDAQ: RVNC ) ResMed Inc.
   ObsEva and Selecta Bio up premarket on bullish ratings  2020/01/29 12:04:04 Seeking Alpha
ObsEva (NASDAQ:OBSV) initiated with Buy rating and $19 (395% upside) price target at Kempen & Co. Shares up 8% premarket. Selecta Biosciences (NASDAQ:SELB)
   Earnings Scheduled For March 12, 2020  2020/03/12 08:51:26 Benzinga Feeds
Companies Reporting Before The Bell Dollar General Corporation (NYSE: DG ) is projected to report quarterly earnings at $2.02 per share on revenue of $7.15 billion. Genesco Inc. (NYSE: GCO ) is estimated to report quarterly earnings at $2.75 per share on revenue of $680.43 million. BEST Inc. (NYSE: BEST ) is expected to report quarterly earnings at $0.42 per share on revenue of $10.90 billion. 58.com Inc. (NYSE: WUBA ) is projected to report quarterly earnings at $0.80 per share on revenue of $587.26 million. Genesis Healthcare, Inc. (NYSE: GEN ) is estimated to report quarterly loss at $0.11 per share on revenue of $1.09 billion. Spartan Motors, Inc. (NASDAQ: SPAR ) is expected to report quarterly earnings at $0.36 per share on revenue of $230.00 million. Party City Holdco Inc. (NYSE: PRTY ) is estimated to report quarterly earnings at $0.88 per share on revenue of $748.82 million. RadNet, Inc. (NASDAQ: RDNT ) is projected to report quarterly earnings at $0.15 per share on revenue of $294.16 million.
   Selecta Biosciences to Host Conference Call and Webcast to Discuss Fourth Quarter and Full-Year 2019 Financial Results and Recent Operational Highlights | MarketScreener  2020/03/05 13:01:10 MarketScreener
WATERTOWN, Mass., March 05, 2020 -- Selecta Biosciences, Inc. , a clinical-stage biotechnology company focused on unlocking the full potential of biologic therapies based on its immune… | March 5, 2020
   The Daily Biotech Pulse: LogicBio Slapped With Clinical Hold, Agile Inks Debt Deal Ahead of Twirla Approval, Gilead Builds Stake In Sierra Oncology  2020/02/11 12:23:06 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Feb. 10) AbbVie Inc (NYSE: ABBV ) Allergan plc (NYSE: AGN ) )(reacted to better-than-expected results and comments that its deal to be acquired by AbbVie is on track to close by the first quarter) Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY ) Apellis Pharmaceuticals Inc (NASDAQ: APLS ) Aptose Biosciences Inc (NASDAQ: APTO ) Arcutis Biotherapeutics Inc (NASDAQ: ARQT ) Ascendis Pharma A/S (NASDAQ: ASND ) AtriCure Inc. (NASDAQ: ATRC ) ChemoCentryx Inc (NASDAQ: CCXI ) Co-Diagnostics Inc (NASDAQ: CODX )(announced sales of its new coronavirus test ) Cue Biopharma Inc (NASDAQ: CUE ) Deciphera Pharmaceuticals Inc (NASDAQ: DCPH ) DexCom, Inc. (NASDAQ: DXCM ) Esperion Therapeutics Inc (NASDAQ: ESPR ) Fulgent Genetics Inc (NASDAQ: FLGT ) GALAPAGOS NV/S ADR (NASDAQ: GLPG ) Insulet Corporation (NASDAQ: PODD ) Kodiak Sciences Inc (NASDAQ: KOD )(reacted to positive data readout from early-stage study of experimental drug to treat eye disorders) Masimo Corporation (NASDAQ: MASI ) Novartis AG (NYSE: NVS ) Pacira Biosciences Inc (NASDAQ: PCRX ) Principia Biopharma Inc (NASDAQ: PRNB ) PTC Therapeutics, Inc (NASDAQ: PTCT ) Revance Therapeutics Inc (NASDAQ: RVNC ) ResMed Inc.
   ObsEva and Selecta Bio up premarket on bullish ratings  2020/01/29 12:04:04 Seeking Alpha
ObsEva (NASDAQ:OBSV) initiated with Buy rating and $19 (395% upside) price target at Kempen & Co. Shares up 8% premarket. Selecta Biosciences (NASDAQ:SELB)
   The Daily Biotech Pulse: Roche Reports Positive SMA Data Readout, Vir Biotech To Work On Virus Treatment  2020/01/23 12:24:36 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Jan. 22) 10X Genomics Inc (NASDAQ: TXG ) Abbott Laboratories (NYSE: ABT )(reported strong fourth-quarter results and issued in-line guidance) Apellis Pharmaceuticals Inc (NASDAQ: APLS ) Applied Genetic Technologies Corp (NASDAQ: AGTC ) AtriCure Inc. (NASDAQ: ATRC ) BIO-TECHNE Corp (NASDAQ: TECH ) Bristol-Myers Squibb Co (NYSE: BMY ) Cardiovascular Systems Inc (NASDAQ: CSII ) Dr.Reddy's Laboratories Ltd (NYSE: RDY ) Eli Lilly And Co (NYSE: LLY ) Fortress Biotech (NASDAQ: FBIO ) Horizon Therapeutics PLC (NASDAQ: HZNP )( received FDA nod for its thyroid eye disease drug) Insulet Corporation (NASDAQ: PODD ) Medtronic PLC (NYSE: MDT ) Masimo Corporation (NASDAQ: MASI ) Medpace Holdings Inc (NASDAQ: MEDP ) Nevro Corp (NYSE: NVRO ) Novocure Ltd (NASDAQ: NVCR )(announced coverage in Israel for its Optune in combination with temozolomide for the treatment of newly-diagnosed glioblastoma) Prevail Therapeutics Inc (NASDAQ: PRVL ) Repligen Corporation (NASDAQ: RGEN ) ResMed Inc. (NYSE: RMD ) Selecta Biosciences Inc (NASDAQ: SELB ) SI-Bone Inc (NASDAQ: SIBN ) Soligenix, Inc.
   Earnings Scheduled For March 12, 2020  2020/03/12 08:51:26 Benzinga Feeds
Companies Reporting Before The Bell Dollar General Corporation (NYSE: DG ) is projected to report quarterly earnings at $2.02 per share on revenue of $7.15 billion. Genesco Inc. (NYSE: GCO ) is estimated to report quarterly earnings at $2.75 per share on revenue of $680.43 million. BEST Inc. (NYSE: BEST ) is expected to report quarterly earnings at $0.42 per share on revenue of $10.90 billion. 58.com Inc. (NYSE: WUBA ) is projected to report quarterly earnings at $0.80 per share on revenue of $587.26 million. Genesis Healthcare, Inc. (NYSE: GEN ) is estimated to report quarterly loss at $0.11 per share on revenue of $1.09 billion. Spartan Motors, Inc. (NASDAQ: SPAR ) is expected to report quarterly earnings at $0.36 per share on revenue of $230.00 million. Party City Holdco Inc. (NYSE: PRTY ) is estimated to report quarterly earnings at $0.88 per share on revenue of $748.82 million. RadNet, Inc. (NASDAQ: RDNT ) is projected to report quarterly earnings at $0.15 per share on revenue of $294.16 million.
   Selecta Biosciences to Host Conference Call and Webcast to Discuss Fourth Quarter and Full-Year 2019 Financial Results and Recent Operational Highlights | MarketScreener  2020/03/05 13:01:10 MarketScreener
WATERTOWN, Mass., March 05, 2020 -- Selecta Biosciences, Inc. , a clinical-stage biotechnology company focused on unlocking the full potential of biologic therapies based on its immune… | March 5, 2020
   The Daily Biotech Pulse: LogicBio Slapped With Clinical Hold, Agile Inks Debt Deal Ahead of Twirla Approval, Gilead Builds Stake In Sierra Oncology  2020/02/11 12:23:06 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Feb. 10) AbbVie Inc (NYSE: ABBV ) Allergan plc (NYSE: AGN ) )(reacted to better-than-expected results and comments that its deal to be acquired by AbbVie is on track to close by the first quarter) Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY ) Apellis Pharmaceuticals Inc (NASDAQ: APLS ) Aptose Biosciences Inc (NASDAQ: APTO ) Arcutis Biotherapeutics Inc (NASDAQ: ARQT ) Ascendis Pharma A/S (NASDAQ: ASND ) AtriCure Inc. (NASDAQ: ATRC ) ChemoCentryx Inc (NASDAQ: CCXI ) Co-Diagnostics Inc (NASDAQ: CODX )(announced sales of its new coronavirus test ) Cue Biopharma Inc (NASDAQ: CUE ) Deciphera Pharmaceuticals Inc (NASDAQ: DCPH ) DexCom, Inc. (NASDAQ: DXCM ) Esperion Therapeutics Inc (NASDAQ: ESPR ) Fulgent Genetics Inc (NASDAQ: FLGT ) GALAPAGOS NV/S ADR (NASDAQ: GLPG ) Insulet Corporation (NASDAQ: PODD ) Kodiak Sciences Inc (NASDAQ: KOD )(reacted to positive data readout from early-stage study of experimental drug to treat eye disorders) Masimo Corporation (NASDAQ: MASI ) Novartis AG (NYSE: NVS ) Pacira Biosciences Inc (NASDAQ: PCRX ) Principia Biopharma Inc (NASDAQ: PRNB ) PTC Therapeutics, Inc (NASDAQ: PTCT ) Revance Therapeutics Inc (NASDAQ: RVNC ) ResMed Inc.
   ObsEva and Selecta Bio up premarket on bullish ratings  2020/01/29 12:04:04 Seeking Alpha
ObsEva (NASDAQ:OBSV) initiated with Buy rating and $19 (395% upside) price target at Kempen & Co. Shares up 8% premarket. Selecta Biosciences (NASDAQ:SELB)
   The Daily Biotech Pulse: Roche Reports Positive SMA Data Readout, Vir Biotech To Work On Virus Treatment  2020/01/23 12:24:36 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Jan. 22) 10X Genomics Inc (NASDAQ: TXG ) Abbott Laboratories (NYSE: ABT )(reported strong fourth-quarter results and issued in-line guidance) Apellis Pharmaceuticals Inc (NASDAQ: APLS ) Applied Genetic Technologies Corp (NASDAQ: AGTC ) AtriCure Inc. (NASDAQ: ATRC ) BIO-TECHNE Corp (NASDAQ: TECH ) Bristol-Myers Squibb Co (NYSE: BMY ) Cardiovascular Systems Inc (NASDAQ: CSII ) Dr.Reddy's Laboratories Ltd (NYSE: RDY ) Eli Lilly And Co (NYSE: LLY ) Fortress Biotech (NASDAQ: FBIO ) Horizon Therapeutics PLC (NASDAQ: HZNP )( received FDA nod for its thyroid eye disease drug) Insulet Corporation (NASDAQ: PODD ) Medtronic PLC (NYSE: MDT ) Masimo Corporation (NASDAQ: MASI ) Medpace Holdings Inc (NASDAQ: MEDP ) Nevro Corp (NYSE: NVRO ) Novocure Ltd (NASDAQ: NVCR )(announced coverage in Israel for its Optune in combination with temozolomide for the treatment of newly-diagnosed glioblastoma) Prevail Therapeutics Inc (NASDAQ: PRVL ) Repligen Corporation (NASDAQ: RGEN ) ResMed Inc. (NYSE: RMD ) Selecta Biosciences Inc (NASDAQ: SELB ) SI-Bone Inc (NASDAQ: SIBN ) Soligenix, Inc.

calendar